Abstract:Histone lysine N‐methyltransferase 2C (KMT2C) is involved in transcriptional regulation and DNA damage repair. Mutations in KMT2C have been implicated in the progression, metastasis, and drug resistance of multiple cancer types. However, the roles of KMT2C in the regulation of tumor prognosis, immune cell infiltration and the immune microenvironment in these multiple cancer types remain unclear. Therefore, in the present study, data from The Cancer Genome Atlas and Genotype‐Tissue Expression databases were used for KMT2C expression analyses. Kaplan‐Meier and univariate Cox regression analyses were also performed to investigate the prognostic role of KMT2C. In addition, Gene Set Enrichment Analysis (GSEA) was conducted to study the KMT2C‐related signaling pathways. Tumor immune estimation resource 2 and single‐sample GSEA were conducted to investigate the correlation between KMT2C expression and immune cell infiltrations, and Spearman's analysis was conducted to study the correlations among KMT2C, tumor mutational burden, microsatellite instability, immune regulators, chemokines and immune receptors. Immunohistochemistry of patient kidney tumor samples was performed to verify the correlation between KMT2C and programmed death‐ligand 1 (PD‐L1) expression. Finally, RNA interference, wound healing and colony formation assays were conducted to evaluate the effects of KMT2C expression on cell proliferation and metastasis. The results of the present study demonstrated that KMT2C was highly expressed in multiple cancer types, was a protective factor in kidney renal clear cell carcinoma and ovarian serous cystadenocarcinoma, and a risk factor for lung squamous cell carcinoma and uveal melanoma. In addition, KMT2C levels were negatively correlated with immune‐activated pathways and the infiltration of immune cells, and positively correlated with inhibitory immune factors and tumor angiogenesis. Patients with low KMT2C expression had higher objective response rates to immunotherapy, and drug sensitivity analysis indicated that topoisomerase, histone deacetylase, DOT1‐like histone H3K79 methyltransferase and G9A nuclear histone lysine methyltransferase inhibitors could potentially be used to treat tumors with high KMT2C expression levels. Finally, the KMT2C and PD‐L1 expression levels were shown to be positively correlated, and KMT2C knockdown markedly promoted the proliferation and invasion capacities of A549 cells. In conclusion, the present study revealed that low KMT2C expression may be a promising biomarker for predicting the response of patients with cancer to immunotherapy. Conversely, high KMT2C expression was shown to promote tumor angiogenesis, which may contribute to the formation of the immunosuppressive tumor microenvironment.

Expression and Prognosis of Hexokinase 2 in Canine Mammary Tumors

Diastolic unloading and improved LV pump efficiency early after repair of the insufficient mitral valve.

A pan-cancer analysis of the role of hexokinase II (HK2) in human tumors

Kv 11.1 Expression Is Associated With Malignancy of Canine Mammary Gland Tumors

Interleukin-18 and allergic asthma.

Establishment of a New Cell Line of Canine Mammary Tumor CMT-1026

Comprehensive Analysis of Hexokinase 2 Immune Infiltrates and m6A Related Genes in Human Esophageal Carcinoma

Overexpression of Metabolic Markers HK1 and PKM2 Contributes to Lymphatic Metastasis and Adverse Prognosis in Chinese Gastric Cancer.

Hexokinase 2 Promotes Cell Proliferation and Tumor Formation through the Wnt/β-catenin Pathway-mediated Cyclin D1/c-myc Upregulation in Epithelial Ovarian Cancer

Research progress of good markers for canine mammary carcinoma

Overexpression of PKMYT1 associated with poor prognosis and immune infiltration may serve as a target in triple-negative breast cancer

[Present aspects of tuberculosis of the jaw and the zygoma].

Hexokinase 2 Discerns a Novel Circulating Tumor Cell Population Associated with Poor Prognosis in Lung Cancer Patients

PKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma

Potential Biomarkers of Malignancy in Canine Mammary Neoplasia

Pan‐cancer analysis on the role of KMT2C expression in tumor progression and immunotherapy

Hexokinases 2 promoted cell motility and distant metastasis by elevating fibronectin through Akt1/p-Akt1 in cervical cancer cells

The Correlation of HK2 Gene Expression with the Occurrence, Immune Cell Infiltration, and Prognosis of Renal Cell Carcinoma

Hexokinase-II Expression in Untreated Oral Squamous Cell Carcinoma: Comparison with FDG PET Imaging

Hexokinase 2 Promotes Cell Growth and Tumor Formation Through the Raf/MEK/ERK Signaling Pathway in Cervical Cancer

Expression and Prognostic Value of AKT2 in Non-small Cell Lung Cancer